Current progress in the targeted therapy of breast cancer: Structure-activity correlation and docking studies (2015-2021).

Pandey, Shivanshu; Mondal, Sitanshu; Kajal, Kumari; Kurmi, Balak Das; Verma, Sant Kumar; Patel, Preeti

Pandey, Shivanshu; Mondal, Sitanshu; Kajal, Kumari; Kurmi, Balak Das; Verma, Sant Kumar; Patel, Preeti.

Afiliación

Pandey S; Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.
Mondal S; Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.
Kajal K; Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.
Kurmi BD; Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India.
Verma SK; Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.
Patel P; Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.

Arch Pharm (Weinheim) ; 356(8): e2200602, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37211680

Asunto(s)

Antineoplásicos; Neoplasias de la Mama; Femenino; Humanos; Fosfatidilinositol 3-Quinasas/metabolismo; Proteínas Nucleares/metabolismo; Factor A de Crecimiento Endotelial Vascular; Factores de Transcripción/uso terapéutico; Relación Estructura-Actividad; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/metabolismo; Antineoplásicos/farmacología; Receptor ErbB-2/metabolismo; Proteínas de Ciclo Celular/metabolismo; Proteínas de Ciclo Celular/uso terapéutico

Palabras clave

breast cancer; docking; structure-activity relationship; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Arch Pharm (Weinheim) Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google